Feed Preview


miRNAs in Cardiovascular Biology

miRNAs in Cardiovascular Biology diagram by vetpathologist, Shutterstock
vetpathologist, Shutterstock

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

Top 20 most recent papers
European Review for Medical and Pharmacological Sciences

Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway

European Review for Medical and Pharmacological SciencesMarch 21, 2020
J-Y ZhangJ Sun
Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko

MicroRNA and their potential role in the pathogenesis of hemorrhagic stroke

Zhurnal voprosy neĭrokhirurgii imeni N. N. BurdenkoMarch 25, 2020
I F GareevV V Nazarov
International Journal of Molecular Sciences

The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation

International Journal of Molecular SciencesMarch 12, 2020
Anastasia PoznyakAlexander N Orekhov
Basic Research in Cardiology

Mitochondrial noncoding RNA-regulatory network in cardiovascular disease

Basic Research in CardiologyMarch 7, 2020
Amela JusicEU-CardioRNA COST Action (CA17129)
Balkan Medical Journal

MicroRNA and Cardiovascular Diseases

Balkan Medical JournalFebruary 6, 2020
Hüseyin Altuğ Çakmak, Mehmet Demir
Frontiers in Pharmacology

Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

Frontiers in PharmacologyFebruary 11, 2020
Nik Nur Syazana Binti Nik Mohamed Kamal, Wan Nazatul Shima Shahidan
Pharmacology & Therapeutics

Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases

Pharmacology & TherapeuticsFebruary 28, 2020
Concetta SchianoClaudio Napoli
International Journal of Molecular Sciences

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders

International Journal of Molecular SciencesMarch 20, 2020
Chary Lopez-PedreraCarlos Pérez-Sánchez
Toxicology Research

Serum miRNAs are differentially altered by ethanol and caffeine consumption in rats

Toxicology ResearchFebruary 15, 2020
M MartinezF E Martinez

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2020 Meta ULC. All rights reserved